Study S001995

The Effect of Glucagon-like Peptide 1 (GLP-1) Receptor Agonist on Cerebral Blood Flow Velocity in Stroke Patients

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT02829502
Acronym: EGRABIS1
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE2
Masking: QUADRUPLE
Status: UNKNOWN
Enrollment: 30
Start: 2016-08
Primary completion: 2023-08
Lead sponsor: Christina Kruuse
Conditions: Ischemic Stroke
Interventions: DRUG:Byetta; DRUG:Normosaline
Results posted: FALSE
Individual participant data sharing: NO
Secondary identifiers: EUDRACT_NUMBER:2016-001219-18; NIH:2016

Registered primary outcomes

Changes in the mean flow velocity in the middle cerebral arteries and in cortical oxigination. [Up till 3 hours]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.